You posted " the company still needs to raise money to fund the FDA process"
That was covered Sept 20th pr
September 20, 2010
COLORADO SPRINGS, CO--(Marketwire - September 20, 2010) - Cannabis Science Inc. (OTCBB: CBIS) ("Cannabis Science, CBIS, or Company"), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that its Board of Directors have begun investigating the corporate and legal requirements required to issue dividends to shareholders to create a new class of common shares. The company is in advanced negotiations with several groups pursuing funding opportunities for up to $5 million between $1.00 and $3.00 per new share. The proceeds will be used to fund FDA clinical trials, acquisitions, and further product research and development.
